Ilyang Pharm (007570) — Free Cash Flow Generation Index
Ilyang Pharm (007570) has a Free Cash Flow Generation Index of -0.47x as of June 2025. Free cash flow of ₩-1.06 Billion represents 0% of operating cash flow (₩2.26 Billion). Read Ilyang Pharm (007570) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ilyang Pharm Free Cash Flow Generation Index (2003–2024)
Historical FCF Generation Index trend for Ilyang Pharm across 12 annual periods. Explore Ilyang Pharm (007570) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Ilyang Pharm (2003–2024)
Year-by-year Free Cash Flow Generation Index for Ilyang Pharm. For the full company profile including market capitalisation, see Ilyang Pharm (007570) total market value.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.23x | ₩-35.01 Billion | ₩5.61 Billion | ₩40.62 Billion | ▼ -1311.0% |
| 2023 | 0.51x | ₩6.87 Billion | ₩13.34 Billion | ₩6.47 Billion | ▲ +64.0% |
| 2022 | 0.31x | ₩9.40 Billion | ₩29.94 Billion | ₩4.08 Billion | ▼ -53.9% |
| 2021 | 0.68x | ₩45.67 Billion | ₩67.02 Billion | ₩12.91 Billion | ▲ +19.2% |
| 2020 | 0.57x | ₩32.86 Billion | ₩57.48 Billion | ₩10.17 Billion | ▼ -25.6% |
| 2019 | 0.77x | ₩27.81 Billion | ₩36.19 Billion | ₩2.17 Billion | ▲ +36.6% |
| 2018 | 0.56x | ₩12.44 Billion | ₩22.12 Billion | ₩1.55 Billion | ▼ -19.2% |
| 2017 | 0.70x | ₩20.91 Billion | ₩30.03 Billion | ₩3.78 Billion | ▼ -49.6% |
| 2016 | 1.38x | ₩37.29 Billion | ₩26.98 Billion | ₩10.31 Billion | ▼ -1.2% |
| 2015 | 1.40x | ₩56.35 Billion | ₩40.27 Billion | ₩16.07 Billion | ▼ -19.8% |
| 2014 | 1.75x | ₩32.51 Billion | ₩18.63 Billion | ₩13.89 Billion | ▲ +67.6% |
| 2003 | 1.04x | ₩10.50 Billion | ₩10.08 Billion | ₩415.11 Million | — |